ELL anticorps
Aperçu rapide pour ELL anticorps (ABIN498288)
Antigène
Voir toutes ELL AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- This antibody detects endogenous levels of ELL protein. (region surrounding Asp125)
-
Réactivité croisée (Details)
-
Species reactivity (expected):Mouse.
Species reactivity (tested):Human. -
Purification
- Affinity chromatography
-
Pureté
- > 95 % by SDS-PAGE
-
-
-
-
Indications d'application
-
Western Blot: 1/500 - 1/1000. Immunohistochemistry: 1/50 - 1/200.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1,0 mg/mL
-
Buffer
- Phosphate buffered saline (PBS) with0.05 % sodium azide, approx. pH 7.2.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
Autre désignation
- ELL
-
Sujet
- ELL was shown to encode an elongation factor that can increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. ELL is the second elongation factor to be implicated in oncogenesis.Synonyms: C19orf17, Eleven-nineteen lysine-rich leukemia protein, RNA polymerase II elongation factor ELL
-
Poids moléculaire
- approx. 65 kDa
-
ID gène
- 8178
-
NCBI Accession
- NP_006523
-
UniProt
- P55199
Antigène
-